Articles with "point inhibitors" as a keyword



Photo by helloimnik from unsplash

Immune check-point in endometrial cancer

Sign Up to like & get
recommendations!
Published in 2019 at "International Journal of Clinical Oncology"

DOI: 10.1007/s10147-019-01437-7

Abstract: BackgroundEndometrial cancer (EC) is one of the most frequent tumors in women. Despite recent advances in treatment approaches, the prognosis in advanced, recurrent, or metastatic disease remains poor. The aim was to provide the clinician… read more here.

Keywords: immune check; point inhibitors; check point; point ... See more keywords
Photo from wikipedia

Check point inhibitors as therapies for infectious diseases.

Sign Up to like & get
recommendations!
Published in 2017 at "Current opinion in immunology"

DOI: 10.1016/j.coi.2017.07.016

Abstract: The recent successes of immune check point targeting therapies in treating cancer patients has driven a resurgence of interest in targeting these pathways in chronically infected patients. While still in early stages, basic and clinical… read more here.

Keywords: inhibitors therapies; point inhibitors; infectious diseases; check point ... See more keywords
Photo by helloimnik from unsplash

Immunogenomic classification of hepatocellular carcinoma patients for immune check-point inhibitors therapy: cui bono?

Sign Up to like & get
recommendations!
Published in 2022 at "Gut"

DOI: 10.1136/gutjnl-2022-327132

Abstract: Data from the United States, Surveillance, Epidemiology, and End Results Program reveal that hepatocellular carcinoma (HCC) 5- year relative survival is 20.3% livibd.html). ‘Approximately, 1.0% of men and women will be diagnosed with liver and… read more here.

Keywords: hepatocellular carcinoma; check point; point inhibitors; immune check ... See more keywords
Photo from wikipedia

Immune Check Point Inhibitors and Immune-Related Adverse Events in Small Cell Lung Cancer

Sign Up to like & get
recommendations!
Published in 2021 at "Frontiers in Oncology"

DOI: 10.3389/fonc.2021.604227

Abstract: Small cell lung cancer (SCLC) is a malignant solid tumor. In recent years, although immune check point inhibitors (ICIs) have achieved important advances in the treatment of SCLC, immune-related adverse events (irAEs) have occurred at… read more here.

Keywords: immune check; point inhibitors; check point; cell lung ... See more keywords